Share this post on:

product name Levonorgestrel


Description: Levonorgestrel is a female hormone that prevents ovulation. Levonorgestrel is a synthetic progestin that binds to progesterone and androgen receptors but not the estrogen receptor. It induces apoptosis in ovarian epithelium cells. Levonorgestrel suppresses the stimulation of progesterone secretion induced by oLH, dibutyryl-cAMP and Pregnenolone in rats luteal cells. Levonorgestrel also inhibits constrictions evoked by either a high potassium (K(+)) solution or phorbol myristate acetate (PMA) in the absence and presence of extracellular calcium (Ca(2+)). 

References: J Steroid Biochem Mol Biol. 1994;50:161-6; Br J Pharmacol. 2000;130:1911-8; Exp Anim. 2011;60:363-71.



Molecular Weight (MW)

312.45 
Formula

C21H28O2 
CAS No.

797-63-7 
Storage

-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)

DMSO: 45 mg/mL (144.0 mM) 
Water: <1 mg/mL
Ethanol: 2 mg/mL (6.4 mM)
Solubility (In vivo)

 
Synonyms

 

other peoduct :References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/1941801

In Vitro

In vitro activity: Levonorgestrel suppresses the stimulation of progesterone secretion induced by oLH, dibutyryl-cAMP and Pregnenolone in rats luteal cells. Levonorgestrel also inhibits constrictions evoked by either a high potassium (K(+)) solution or phorbol myristate acetate (PMA) in the absence and presence of extracellular calcium (Ca(2+)). Levonorgestrel depresses contractions evoked by Ca(2+) and reduces (45)Ca(2+) influx in depolarized veins. Levonorgestrel increases levels of cyclic AMP and inhibits PMA-induced activation of protein kinase C in veins. Levonorgestrel causes endothelium-independent relaxations of jugular veins via inhibition of Ca(2+) entry and of protein kinase Cactivation. Levonorgestrel inhibition of both estrogen-induced pituitary weight increment and hyperprolactinemia is reduced by mifepristone, whereas Flutamide is unable to block Levonorgestrel effects. 


Kinase Assay:


Cell Assay

In Vivo Levonorgestrel down-regulates the mRNA expression of follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR), estrogen receptor (ER) β and progesterone receptor (PR) in the ovary, and ERα and PR in the uterus of Mongolian gerbils. Levonorgestrel causes a significant upregulation of the mRNA expression of the gene encoding luteinising hormone β-subunit (lhβ) and the suppression of the mRNA expression of the gene encoding follicle-stimulating hormone β-subunit (fshβ) in the pituitary of both male and female roach. Levonorgestrel disrupts the reproductive system of pubertalroach by affecting the pituitary gonadotropin expression and the sex steroid levels in pubertal roach (Rutilus rutilus).   
Animal model  
Formulation & Dosage  
References  J Steroid Biochem Mol Biol. 1994 Aug;50(3-4):161-6; Br J Pharmacol. 2000 Aug;130(8):1911-8; Exp Anim. 2011;60(4):363-71. 

XMD8-93

Share this post on:

Author: Sodium channel